Iqra Shahid

Iqra Shahid

Auto-generated profile, based on publicly available information

Iqra Shahid

King Edward Medical University, Lahore, Pakistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
AAAbdullah Afridi
Abdullah Afridi
AZAyehsa Zulfiqar
Ayehsa Zulfiqar
FSFatima Sajjad
Fatima Sajjad
ISIqra Shahid
Iqra Shahid
HHHira Habib
Hira Habib
KKKamil Ahmad Kamil
Kamil Ahmad Kamil
Background: The primary treatment for colorectal cancer, which is very prevalent, is surgery. Anastomotic leaking poses a significant risk following surgery. Intestinal perfusion can be objectively and instantly assessed with indocyanine green fluorescence imaging, which may lower leakage rates and enhance surgical results. Methods: PubMed, Embase, and Web of Science databases were systematically searched using relevant keywords from inception until 5th of March 2025. Eight studies were included after final screening. Outcomes were reported as overall anastomotic leakage, wound infection, paralytic ileus, mechanical ileus, and post-operative hospital stay. Interstudy heterogeneity was assessed using I 2 and X 2 statistics (I 2 > 50% = significant heterogeneity). Statistical calculations were performed using Review Manager 5.4.1 (The Cochrane Collaboration, Copenhagen, Denmark), with a p-value of < 0.05 indicating statistical significance. Results: This meta-analysis includes 4047 patients from eight investigations (2026 indocyanine green (ICG) group, 2021 non-ICG group). Overall anastomotic leak risk was considerably decreased with ICG use (risk ratio (RR) = 0.66; 95% CI: 0.54–0.81; p < 0.0001) and showed no heterogeneity (I 2 = 0%). There was no heterogeneity (I 2 = 0%) in the Grade A leakage occurrence, which was considerably lower in the ICG group (RR = 0.34; 95% CI: 0.16–0.72; p = 0.005). With little heterogeneity (I 2 = 8.6%), combined leakage grades also supported ICG use (RR = 0.54; 95% CI: 0.35–0.84; p = 0.006). ICG was associated with a substantial decrease in Clavien–Dindo Grade I complications (RR = 0.67; 95% CI: 0.49–0.92; p = 0.01) without heterogeneity (I 2 = 0%). Initial postoperative hospital stays, mechanical ileus, paralytic ileus, and abdominal bleeding did not differ significantly. Although there was no heterogeneity (I 2 = 0%), sensitivity analysis showed that the ICG group had a substantially longer postoperative stay (MD = 0.27; 95% CI 0.05–0.49; p = 0.02) and significantly fewer wound infections (RR = 0.17; 95% CI 0.04–0.76; p = 0.02). With noteworthy heterogeneity (I 2 = 70%), the ICG group’s operating time was significantly longer (MD = 8.26 min; 95% CI 0.52–16.00; p = 0.04). Conclusion: Although indocyanine green fluorescence imaging may marginally lengthen the recovery period and duration of operation, it dramatically lowers anastomotic leakage and wound infections following colorectal surgery, enhancing results.

12 November 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
TFTehreem Mbbs Fatima
Tehreem Mbbs Fatima
AMAeliya Mbbs Mirza
Aeliya Mbbs Mirza
FFFaiza Fatima
Faiza Fatima
RKRiyan Imtiaz Mbbs Karamat
Riyan Imtiaz Mbbs Karamat
BABilal Ahmad
Bilal Ahmad
AAAymar Akilimali
Aymar Akilimali
Autoimmune disorders exhibit intricate pathology. Their mechanisms are complex, which attenuates the need for novel therapeutic interventions. Frexalimab, a potent monoclonal antibody targeting the dysregulated CD40-CD40L pathway, stands out as a formidable weapon against the assault of inflammation and tissue devastation. Diverse electronic databases were searched using relevant keywords to extract data on the role of Frexalimab in combating various autoimmune diseases. This review highlights Frexalimab’s efficacy in improving various disability indicators of relapsing multiple sclerosis (RMS), alleviating fatigue in primary Sjögren’s syndrome (PSJS), and improving glycemic control in diabetic patients. Across multiple trials, its favorable safety profile has proven its superiority over first-generation drugs in minimizing side effects. Indeed, Frexalimab has become a harbinger of hope in the fight against autoimmune diseases and has pioneered a unique and unchallenging way for tackling complex autoimmune diseases in the clinical realm, however, further large-scale trials are needed to establish its therapeutic benefits across different autoimmune conditions.

14 November 2025 in Medicine
Verified
Journal Article
Open access
UIUsama Idrees
Usama Idrees
SNSafa Nasir
Safa Nasir
MMMohammed Dheyaa Marsool Marsool
Mohammed Dheyaa Marsool Marsool
HSHumza Saeed
Humza Saeed
ZFZainab Fatima
Zainab Fatima
MAMuhammad Husnain Ahmad
Muhammad Husnain Ahmad
Viral hepatitis (VH) remains a leading cause of preventable mortality in the United States (US). Despite advancements in antiviral therapies, disparities in VH-related mortality persist across demographic, racial, and geographic groups. This study analyzes trends in VH-related mortality among US adults between 1999 and 2020 to identify high-risk subgroups and inform public health interventions. This retrospective cohort study analyzed VH-related deaths among US adults (≥25 years). Data were obtained from the CDC WONDER database, with cases identified using the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes B15–B19. Age-adjusted mortality rates (AAMRs) were calculated per 1,00,000 individuals and stratified by age, gender, race and geographical location. Temporal trends in mortality were analyzed by estimating annual percentage changes (APCs) in the AAMRs using the joinpoint regression model. A total of 3,59,035 VH-related deaths were recorded among US adults during 1999 to 2020 with a cumulative overall AAMR of 7.36 (95% CI: 7.33–7.38). Overall, the AAMRs increased significantly from 1999 to 2013 (APC: +3.21; P < .01), followed by a significant decline until 2020 (APC: −5.61; P < .01). Men exhibited higher AAMRs than women, with middle-aged adults (45–64 years) most affected compared to young (25–44 years) and older adults (65 to 85+ years). Non-Hispanic (NH) American Indians/Alaska experienced the highest AAMRs followed by NH Blacks/African Americans, Hispanics, NH Asians/Pacific Islanders and NH Whites populations. Geographically, mortality rates were higher in urban areas than in rural areas, in the Western region relative to other regions and in the District of Columbia compared to other states. Significant disparities in VH-related mortality persist across demographic and geographic subgroups, with particularly higher rates among men, NH American Indian/Alaska Native population, middle-aged adults, and residents of urban and Western US regions. Targeted public health strategies are essential to address these inequities and improve outcomes.

14 October 2025 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
AAAbdullah Afridi
Abdullah Afridi
MQMaria Qadri
Maria Qadri
FSFatima Sajjad
Fatima Sajjad
HHHira Habib
Hira Habib
IKIqra Khan
Iqra Khan
KKKamil Ahmad Kamil
Kamil Ahmad Kamil

29 July 2025 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
ISIqra Shahid
Iqra Shahid
HAHadia Ahmad
Hadia Ahmad
SASaad Ashraf
Saad Ashraf
QMQasim Mehmood
Qasim Mehmood
AIAzka Ijaz
Azka Ijaz
ACAayush Chaulagain
Aayush Chaulagain
Introduction: Peripheral circulatory complication (PCC), a significant complication of type 2 diabetes mellitus (T2DM), poses a considerable mortality burden in the United States. This study aimed to analyse demographic and geographic disparities in PCC‐related mortality in T2DM patients from 1999 to 2020. Methods: Utilising the CDC WONDER database, we utilised death certificates to identify PCC‐related deaths using ICD‐10 Code E11.5 and calculated age‐adjusted mortality rates (AAMRs) per 1,000,000 individuals. Joinpoint regression analysis was used to assess annual percent changes (APCs) in mortality rates. Results: PCC caused 81,793 deaths. The AAMR increased from 1999 to 2004 (APC: 5.88, 95% CI: 2.44 to 12.70), followed by a decrease from 2004 to 2014 (APC: −3.70, 95% CI: −5.83 to −2.45), and an increase again until 2020 (APC: 8.34, 95% CI: 6.05 to 11.50). Males consistently exhibited higher mortality rates (AAMR: 11.08, 95% CI: 11.00 to 11.6) than females (AAMR: 8.34, 95% CI: 8.26 to 8.43). Racial/ethnic disparities were evident, with American Indian or Alaskan natives showing the highest AAMR (19.76) compared to Asian or Pacific Islanders (6.11). Geographic disparities were observed, with the Midwest region (AAMR: 12.86) and West Virginia (AAMR: 18.52) exhibiting significantly higher mortality rates. Conclusion: Mortality trends associated with PCC in T2DM patients have shown complex trajectories, with notable disparities across demographic and geographic lines. Further research is needed to comprehensively understand the dynamics of PCC and its implications for public health.

13 September 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
ISIqra Shahid
Iqra Shahid
ARAhmed Raza
Ahmed Raza
IQInshrah Qureshi
Inshrah Qureshi
UCUmaima Cheema
Umaima Cheema
SMSiraj Ul Muneer
Siraj Ul Muneer
AAAymar Akilimali
Aymar Akilimali
Background: Artificial intelligence (AI) and machine learning (ML) have significantly advanced medical diagnostics and surgical procedures, particularly in spinal and cranial surgery. Robotic-assisted surgery has emerged as a transformative approach, offering increased precision, reduced intraoperative complications, and improved surgical outcomes. This review examines the effectiveness and reliability of AI in spinal and cranial diagnosis, its integration into robotic-assisted surgical interventions, and the associated ethical concerns. Method: An extensive literature search was search was conducted on different search engines such as PubMed, Google Scholar, and Scopus to find relevant articles. Result: Findings suggest that AI models exhibit high accuracy in detecting spinal and cranial pathologies. ML algorithms contribute to enhanced prognostic assessments and decision-making in neurosurgery. Robotic-assisted surgeries have superior accuracy, lower radiation exposure, and fewer postoperative complications compared to conventional methods. However, challenges such as data biases, lack of transparency in AI decision-making, regulatory hurdles, and the high costs of AI-driven interventions pose significant barriers to widespread adoption. Ethical concerns, including patient privacy, algorithmic bias, and the potential overreliance on AI, must be addressed to ensure responsible integration into clinical practice. Conclusion: Use of AI and machine learning improves the diagnostic outcomes and decreases post op complications in the field of spinal and cranial surgery. But certain challenges such as ethical concerns and technical hurdles should be sorted out with effective planning. Further research is necessary to refine AI-driven interventions, enhance cost-effectiveness, and to make sure ethical and equitable implementation of AI and robotic surgery in neurosurgical care.